Company / Net Debt per Share
Phathom Pharmaceuticals, Inc. Net Debt per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
$1.15
FY2025
5-year range
-$5.87 / $1.15
FY2021-FY2025
Trend
+169.8%
vs FY2024
Sector context
#29 of 82
Health Care
What the data says
At $1.15, Phathom Pharmaceuticals, Inc.'s net debt per share ranks #54 of 82 in the Health Care sector. Increased from $-5.87 to $1.15 over the past 2 years.
Based on SEC 10-K filings.
1.15 in FY2025.
Increased from $-5.87 to $1.15 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#54 of 82 in Health CareTop 65% of 82This company $1.15 Sector average $1.13
▼
+2.2% above sector average
Key checks
Key Insights
- In FY2025, net debt per share increased 169.8% year-over-year.
- Ranks #29 out of 82 companies in the Health Care sector.
- Lowest net debt per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -6.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.15 | +169.8% |
| FY2024 | -$1.65 | +71.8% |
| FY2023 | -$5.87 | -282.1% |
| FY2022 | -$1.54 | +39.2% |
| FY2021 | -$2.53 | +66.1% |
| FY2020 | -$7.46 | +61.6% |
| FY2019 | -$19.44 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026